Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from National Cancer Institute

21:46 EDT 15th October 2018 | BioPortfolio

Here are the most relevant search results for "National Cancer Institute" found in our extensive news archives from over 250 global news sources.

More Information about National Cancer Institute on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about National Cancer Institute for you to read. Along with our medical data and news we also list National Cancer Institute Clinical Trials, which are updated daily. BioPortfolio also has a large database of National Cancer Institute Companies for you to search.

Showing News Articles 1–25 of 52 from National Cancer Institute

Monday 17th September 2018

Alcohol and Cancer Risk

A fact sheet that summarizes the evidence linking alcohol consumption to the risk of various cancers. Includes information about factors that affect the risk of alcohol-associated cancers, such as a person’s genes and tobacco use.

Wednesday 5th September 2018

Cancer Clusters

A fact sheet that describes what constitutes a cancer cluster, the process for reporting and investigating suspected clusters, and the challenges in investigating suspected clusters.

Monday 27th August 2018

Statement from NCI Director Dr. Norman E. Sharpless on the Death of Senator John McCain

Senator John McCain, a long-time supporter of cancer research, passed away on August 25.

Tuesday 14th August 2018

Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer

Results from a randomized clinical trial show patients with HPV-positive oropharyngeal cancer treated with radiation and cetuximab had inferior survival compared to the current standard treatment with radiation and cisplatin. The trial’s goal was to find a less toxic treatment approach without compromising survival.

Tuesday 17th July 2018

NIH and Prostate Cancer Foundation launch large study on aggressive prostate cancer in African-American men

RESPOND is the largest coordinated study on biological and non-biological factors associated with aggressive prostate cancer in African-American men. The study is an effort to learn why these men disproportionally experience aggressive disease.

Tuesday 10th July 2018

NCI and VA collaborate to boost veterans’ access to cancer clinical trials

NCI and the Department of Veterans Affairs (VA) are launching the NAVIGATE program at 12 VA facilities across the country to make it easier for veterans to participate in NCI-sponsored clinical trials.

Tuesday 19th June 2018

African American Men and Prostate Cancer: Be Your Own Advocate and Understand Screening

This article addresses prostate cancer screening and the research around its potential benefits and harms.

Monday 18th June 2018

Clinical Trials Awareness - Hispanic

ThIS article explain to Hispanic audiences that clinical trials are a critical tool that researchers use to test whether new methods are better and safer than existing methods. Without clinical trials, many of the recent advances in cancer would not have been possible. The article also points to two valuable web resources: Learn About Clinical Trials from the National Cancer Institute and NIH Clin...

LGBT Community: Cancer and Smoking

Information on smoking and cancer in the LGBT community and where to get help with quitting.

Hispanics - Diversifying the Ranks of Cancer Researchers To Help Reduce Cancer Disparities

This article talks about efforts to diversify the cancer research enterprise. As the research community invests more resources into investigating cancer and other health disparities, improving diversity in the research ranks is critical. Underrepresented researchers bring more to the table than education and training credentials.

African Americans - Diversifying the Ranks of Cancer Researchers To Help Reduce Cancer Disparities

This article talks about efforts to diversify the cancer research enterprise. As the research community invests more resources into investigating cancer and other health disparities, improving diversity in the research ranks is critical. Underrepresented researchers bring more to the table than education and training credentials.

In the Spotlight - Dr. Tanya Agurs-Collins

Meet Dr. Tanya Agurs-Collins, a program director and nutritionist at the NCI, whose grandmother influenced her interest in nutrition and healthy eating.

Hispanics and Pancreatic Cancer: Things to Know

One of the leading causes of cancer-related deaths among Hispanics in the United States is a rare but often fatal disease known as pancreatic cancer. This cancer, which is often detected only after it has spread beyond the pancreas, strikes people of all races and ethnicities.

African Americans and Pancreatic Cancer: Things to Know

When NFL Hall of Famer Gene Upshaw died of pancreatic cancer in 2008, it was the first time that many Americans had heard of the disease. Like many patients with this deadly cancer, the 63-year-old Upshaw died a short period after his diagnosis. Upshaw’s death shone a spotlight on a disease that, although rare, disproportionately affects African Americans.

Lung Cancer Awareness

These articles are a Q&A interview with Dr. Christopher Lathan M.D., of the Dana-Farber Cancer Institute in Boston. Dr. Lathan treats patients with lung disease.

Monday 4th June 2018

New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments

A novel approach to immunotherapy developed by NCI researchers has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. The findings were published in Nature Medicine.

Sunday 3rd June 2018

TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy

Findings from the TAILORx clinical trial show chemotherapy does not benefit most women with early breast cancer. The new data, released at the 2018 ASCO annual meeting, will help inform treatment decisions for many women with early-stage breast cancer.

Friday 25th May 2018

Human Papillomavirus (HPV) Vaccines

A fact sheet about human papillomavirus (HPV) vaccines for the prevention of infection with certain types of HPV, which is the major cause of cervical cancer.

Tuesday 22nd May 2018

Annual Report to the Nation: overall cancer mortality continues to decline, prostate cancer mortality has stabilized

The 2018 Annual Report to the Nation on the Status of Cancer finds overall cancer death rates continue to decline and cancer incidence dropped in men and remained stable in women. A companion study reports on recent changes in prostate cancer trends.

Monday 21st May 2018

Biological Therapies for Cancer

A fact sheet that provides an overview of how the immune system functions and describes the actions of biological therapies, such as monoclonal antibodies, cytokines, therapeutic vaccines, the bacterium bacillus Calmet-Guérin, cancer-killing viruses, gene therapy, and adoptive T-cell transfer.

Monday 14th May 2018

Targeted Cancer Therapies

A fact sheet that describes targeted cancer therapies, which are drugs that interfere with specific molecules involved in cancer cell growth and survival.

Wednesday 2nd May 2018

Common Moles, Dysplastic Nevi, and Risk of Melanoma

A fact sheet about moles and how some moles may be related to melanoma, which is the most serious type of skin cancer. The fact sheet includes photos of differences between moles and cancer, and discusses risk factors for melanoma.

Tuesday 1st May 2018

Angiogenesis Inhibitors

A fact sheet that describes cancer-fighting agents that block the growth of blood vessels that support tumor growth.

Monday 2nd April 2018

Chemicals in Meat Cooked at High Temperatures and Cancer Risk

A fact sheet that explains how certain chemicals are formed in meat that is cooked using high-temperature methods, such as pan frying or grilling, and describes the results of research on the relationship between consumption of these chemicals and cancer risk.

Wednesday 28th March 2018

NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas

Interim results from a clinical trial for patients with desmoid tumors or aggressive fibromatosis (DT/DF) show that the drug sorafenib tosylate (Nexavar) extended progression-free survival compared with a placebo.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks